OOIR: Observatory of International Research

Papers

(The H4-Index of mAbs is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
In silico prediction of post-translational modifications in therapeutic antibodies	292
Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms	217
Correction	120
Development of a novel, high-throughput imaged capillary isoelectric focusing-Western method to characterize charge heterogeneity of monoclonal antibody heavy and light chains	95
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex	86
A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability	85
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma	72
Biologics developability data analysis using hierarchical clustering accelerates candidate lead selection, optimization, and preformulation screening	66
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries	61
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties	60
Phenotypic whole-cell screening identifies a protective carbohydrate epitope on Klebsiella pneumoniae	59
An antibody developability triaging pipeline exploiting protein language models	57
Correction	55
Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn	46
Application of quantitative protein mass spectrometric data in the early predictive analysis of membrane-bound target engagement by monoclonal antibodies	44
Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning	41
Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies	38
A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies	38
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis	38
The proximity of the N- and C- termini of bovine knob domains enable engineering of target specificity into polypeptide chains	36
The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics	36
Unambiguous identification of α-Gal epitopes in intact monoclonal antibodies by NMR spectroscopy	36
Correction	35
Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity	34
A mouse pancreatic organoid model to compare PD-L1 blocking antibodies	34

GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery	33
Mitochondrial membrane potential-enriched CHO host: a novel and powerful tool for improving biomanufacturing capability	30
Impact of IgG subclass on monoclonal antibody developability	30
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs	30